KurmanRJShihI-M.The origin and pathogenesis of epithelial ovarian cancera proposed unifying theory. Am J Surg Pathol2010;
34:433
2.
YallapuMMMaherDMSundramVBellMCJaggiMChauhanSC.Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res2010;
3:11
3.
BrainKESmitsSSimonAEForbesLJRobertsCRobbéIJStewardJWhiteCNealRDHansonJ.Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample. BMC Cancer2014;
14:171
4.
MenonUGriffinMGentry-MaharajA.Ovarian cancer screening – current status, future directions. Gynecol Oncol2014;
132:490–5
5.
LupiaMCavallaroU.Ovarian cancer stem cells: still an elusive entity?Mol Cancer2017;
16:64
6.
FujioKKomaiTInoueMMoritaKOkamuraTYamamotoK.Revisiting the regulatory roles of the TGF-β family of cytokines. Autoimmun Rev2016;
15:917–22
7.
AragónEWangQZouYMorganiSMRuizLKaczmarskaZSuJTornerCTianLHuJ.Structural basis for distinct roles of SMAD2 and SMAD3 in FOXH1 pioneer-directed TGF-β signaling. Genes Dev2019;
33:1506–24
8.
ZhaoMMishraLDengC-X.The role of TGF-β/SMAD4 signaling in cancer. Int J Biol Sci2018;
14:111
9.
ZhaoSVenkatasubbaraoKLazorJWSperryJJinCCaoLFreemanJW.Inhibition of STAT3Tyr705 phosphorylation by Smad4 suppresses transforming growth factor β–mediated invasion and metastasis in pancreatic cancer cells. Cancer Res2008;
68:4221–8
10.
SundeJSDonningerHWuKJohnsonMEPestellRGRoseGSMokSCBradyJBonomeTBirrerMJ.Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-β signaling in ovarian cancer. Cancer Res2006;
66:8404–12
11.
SunG-LLiZWangW-ZChenZZhangLLiQWeiSLiB-WXuJ-HChenL.miR-324-3p promotes gastric cancer development by activating Smad4-mediated wnt/beta-catenin signaling pathway. J Gastroenterol2018;
53:725–39
12.
HernandaPYChenKDasAMSiderasKWangWLiJCaoWBotsSKodachLLDe ManR.SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma. Oncogene2015;
34:5055–68
13.
LiJHuKGongGZhuDWangYLiuHWuX.Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression. Sci Rep2017;
7:1–9
14.
ChuPLiangAJiangAZongL.miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression. Oncol Lett2018;
15:7571–8
15.
ZhouJZhangCZhouBJiangD.miR-183 modulated cell proliferation and apoptosis in ovarian cancer through the TGF-β/Smad4 signaling pathway. Int J Mol Med2019;
43:1734–46
16.
ChanDHuiWWangJYungMHuiLQinYLiangRLeungTXuDChanK.DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling. Oncogene2017;
36:1404–16
17.
YangJWangYZengZQiaoLZhuangLGaoQMaDHuangX.Smad4 deletion in blood vessel endothelial cells promotes ovarian cancer metastasis. Int J Oncol2017;
50:1693–700
18.
FrumanDAChiuHHopkinsBDBagrodiaSCantleyLCAbrahamRT.The PI3K pathway in human disease. Cell2017;
170:605–35
19.
ChenHZhouLWuXLiRWenJShaJWenX.The PI3K/AKT pathway in the pathogenesis of prostate cancer. Front Biosci2016;
21:1084–91
20.
Guerrero-ZotanoAMayerIAArteagaCL.PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment. Cancer Metast Rev2016;
35:515–24
ZhangJ-GWangJ-JZhaoFLiuQJiangKYangG-h.MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta2010;
411:846–52
24.
SuzukiHIKiyonoKMiyazonoKJA.Regulation of autophagy by transforming growth factor-β (TGF-β) signaling. Autophagy2010;
6:645–7
25.
SirajAKPratheeshkumarPDivyaSPParvathareddySKBuRMasoodiTKongYThangavelSAl-SaneaNAshariLH.TGFβ-induced SMAD4-dependent apoptosis proceeded by EMT in CRC. Mol Cancer Ther2019;
18:1312–22
26.
ShaoXLaiDZhangLXuHJSR.Induction of autophagy and apoptosis via PI3K/AKT/TOR pathways by azadirachtin a in spodoptera litura cells. Sci Rep2016;
6:35482
27.
NealCLXuJLiPMoriSYangJNealNNZhouXWyszomierskiSLYuD.Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit. Oncogene2012;
31:897–906
28.
YangYLiuLZhangYGuanHWuJZhuXYuanJLiM.MiR‐503 targets PI3K p85 and IKK‐β and suppresses progression of non‐small cell lung cancer. Int J Cancer2014;
135:1531–42
29.
LuoJCantleyLC.Then negative regulation of phosphoinositide 3-kinase signaling by p85 and its implication in cancer. Cell Cycle2005;
4:1309–12
30.
LengALiuTHeYLiQZhangG.Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer. Exp Mol Pathol2009;
87:48–53
31.
LefterLPSunamuraMFurukawaTTakedaKKotobukiNOshimuraMMatsunoSHoriiA.Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype. Clin Cancer Res2003;
9:5044–52
32.
OhikeNJürgensenAPipeleers-MarichalMKlöppelG.Mixed ductalendocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells. Virchows Arch2003;
442:258–65
33.
SchneiderDKleeffJBerberatPOZhuZKorcMFriessHBüchlerMW.Induction and expression of βig-h3 in pancreatic cancer cells. Biochim Biophys Acta2002;
1588:1–6
34.
PizziSAzzoniCBassiDBottarelliLMilioneMBordiC.Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer2003;
98:1273–82
35.
IjichiHIkenoueTKatoNMitsunoYTogoGKatoJKanaiFShiratoriYOmataM.Systematic analysis of the TGF-β-Smad signaling pathway in gastrointestinal cancer cells. Biochem Biophys Res Commun2001;
289:350–7
36.
BaldusSESchwarzELohreyCZapatkaMLandsbergSHahnSASchmidtDDienesHPSchmiegelWHSchwarte-WaldhoffI.Smad4 deficiency in cervical carcinoma cells. Oncogene2005;
24:810
CarneroAParamioJM.The PTEN/PI3K/AKT pathway in vivo, cancer mouse models. Front Oncol2014;
4:252
39.
ZhaoMZhouAXuLZhangX.The role of TLR4-mediated PTEN/PI3K/AKT/NF-κB signaling pathway in neuroinflammation in hippocampal neurons. Neuroscience2014;
269:93–101
40.
NakahataSIchikawaTManeesaayPSaitoYNagaiKTamuraTManachaiNYamakawaNHamasakiMKitabayashiI.Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers. Nat Commun2014;
5:3393
